Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Allakos
Allakos
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Allakos
Allakos Summary
Company Summary
Overview
Allakos is a biotechnology company that develops therapeutics targeting allergic, inflammatory, and proliferative diseases. It creates monoclonal antibodies that activate or block inhibitory receptors on immune cells.
Type
Subsidiary
Status
Active
Founded
2012
HQ
San Carlos, CA, US
|
view all locations
Website
https://www.allakos.com/
Cybersecurity rating
ESG rating
40-49 out of 100
|
View all ESG data
Sectors
Healthcare
biotech
pharma
therapy
Homepage
Linkedin
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Dan Janney,
Chairman
Robert Alexander,
Chief Executive Officer
Robert Andreatta,
Director
Linkedin
Paul Walker,
Director
and 3 others
Locations
View all
1 location detected
San Carlos, CA
HQ
United States
825 Industrial Rd #500
Allakos Financials
Summary Financials
Net income (Q1, 2025)
($26.2M)
Cash (Q1, 2025)
$24.2M
EBIT (Q1, 2025)
($26.7M)
Competitors and Similar Companies
Deciphera Pharmaceuticals
Healthcare - Public
Xenikos
Healthcare - Private
Edgewise Therapeutics
Healthcare - Public
Escient Pharmaceuticals
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top